A Call to Arms: Tools for HCV Treaters to Maximize HCV Cure Rates and Advance Toward HCV Elimination

In this 2-hour, CME/CE-certified symposium, expert faculty will discuss the latest data and evidence-based strategies for curing HCV infection in individual patients and eradicating HCV across populations.

Presented for attendees of the 68th AASLD Annual Meeting (or The Liver Meeting®). This event/function is jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC and supported by Gilead Sciences, Inc. This is not an official function/event of the American Association for the Study of Liver Diseases.

Agenda

6:30 PM Registration and Buffet Meal

7:00 PM Program Overview
  Chair: Norah Terrault, MD, MPH

7:10 PM The Path to 100% HCV Elimination
  Chair: Norah Terrault, MD, MPH

7:20 PM The Toolkit to Achieve Cure
  Faculty: Ira M. Jacobson, MD

7:45 PM Key Targets to Reach 100%

  • Engaging the 50%: Increasing Screening and Diagnosis
    Faculty: Jordan J. Feld, MD, MPH
  • Treating the 33%: Expanding Therapy to the Previously Excluded
    Faculty: Christian B. Ramers, MD, MPH
  • Curing the 10%: Evolving Options for DAA-Experienced Patients
    Faculty: Paul Y. Kwo, MD

8:50 PM Concluding Questions and Answers
  Faculty Panel

9:00 PM Adjournment

Events

Date / Time
Event Details

Faculty

Program Director
Norah Terrault, MD, MPH

Professor of Medicine and Surgery
Director, Viral Hepatitis Center
Division of Gastroenterology
University of California, San Francisco
San Francisco, California

Faculty
Jordan J. Feld, MD, MPH

Associate Professor of Medicine
University of Toronto
Hepatologist
Toronto Centre for Liver Disease
Sandra Rotman Centre for Global Health
Toronto, Canada

Faculty
Ira M. Jacobson, MD

Director of Hepatology
NYU Langone Medical Center
New York, New York

Faculty
Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Faculty
Christian Ramers, MD

Assistant Clinical Professor
Division of Infectious Diseases
Department of Medicine
UC San Diego School of Medicine
La Jolla, California
Assistant Medical Director
Division of Research/Special Populations
Family Health Centers of San Diego
San Diego, California

CME

Program Overview
You are invited to attend this live, dynamic symposium on evidence-based strategies for eliminating HCV infection, both at the individual and population levels! This interactive program will feature targeted reviews and discussion by expert faculty on where the HCV field now stands, from screening and diagnosis to expanding therapy to previously excluded populations to curing treatment-experienced patients—all with the goal of eradicating HCV from communities worldwide.

Goal
The goal of this activity is to improve participants’ ability to cure HCV in individual patients and to contribute to efforts to eventually achieve HCV elimination.

Target Audience
This program is intended for physicians, registered nurses, and other healthcare providers who care for patients at risk of or infected with HCV.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Apply strategies to increase rates of HCV screening, diagnosis, and referral in primary care settings
  • Implement approaches to overcome barriers to HCV treatment and cure, including in underserved patient populations
  • Integrate current and emerging treatment options, including regimens appropriate for patients with previous treatment failure

Accreditation

Physicians Continuing Education

Accreditation Statement 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Nursing Continuing Education

Accreditation Statement
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
This educational activity for 2.0 contact hours is provided by Postgraduate Institute for Medicine.

A statement of credit will be issued only upon receipt of a completed activity evaluation form.